ENVB

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended September 30, 2010, for Spatializer Audio Laboratories, Inc. (Note: The input metadata referenced "Enveric Biosciences," but the filing text explicitly identifies the registrant as Spatializer Audio Laboratories, Inc.). The company is a Delaware corporation classified as a shell company and a smaller reporting company. It ceased commercial operations in 2006 after selling substantially all of its intellectual property assets to DTS, Inc. in 2007. The company currently has no active business operations and is seeking merger, acquisition, or business combination opportunities.

Key Financial Metrics

Material Changes vs. Prior Period

• Net Loss: The net loss for the three months ended September 30, 2010, was $(5,613), an increase from $(4,501) in the same period in 2009. For the nine-month period, the loss was $(25,928) compared to $(39,847) in 2009.
• Cash Position: Cash and cash equivalents increased to $4,160 from $1,792 at December 31, 2009. This increase was primarily due to $40,000 in loans from shareholders (Jay Gottlieb and Gregg Schneider) received between January and August 2010 to fund operations.
• Liabilities: Total current liabilities increased significantly to $40,163 from $11,867 at the end of 2009, driven by the new shareholder loans. Accounts payable decreased from $11,867 to $163.
• Equity: Shareholders' equity remained negative, worsening from $(10,075) at December 31, 2009, to $(36,003) at September 30, 2010, due to accumulated operating losses.

Outlook, Risks, and Management Commentary

• Going Concern: The filing explicitly states that the company's circumstances, including significant operating losses and negative working capital, raise substantial doubt about its ability to continue as a going concern. The financial statements do not include adjustments that might result from this uncertainty.
• Liquidity: Management believes current cash reserves are insufficient to meet operating obligations for more than 3 to 6 months without raising additional capital. There is no current source of future cash flow from operations.
• Strategy: The company plans to continue as a public entity solely to seek merger, acquisition, or business combination opportunities. It does not expect to have significant operations until such a transaction is effectuated.
• Tax Assets: The company has net operating loss (NOL) carryforwards of approximately $26.25 million. However, due to a change of control in 2007, it is expected that these NOLs will not be utilized to offset taxable income generated after 2007.
• Legal Proceedings: As of November 10, 2010, the company is not involved in any legal proceedings expected to have a material adverse effect, though litigation risks remain inherent.

Investor Verification Checklist

• Company Identity: Verify that the filing pertains to Spatializer Audio Laboratories, Inc., not Enveric Biosciences, Inc., as indicated in the metadata.
• Capital Sufficiency: Confirm the company's ability to secure additional funding within the next 3-6 months to avoid insolvency, given the $4,160 cash balance and negative working capital.
• Shareholder Loans: Review the terms of the $40,000 loans from shareholders to understand repayment obligations and potential conversion to equity.
• Merger Activity: Monitor for any announcements regarding merger or acquisition targets, as this is the company's sole stated business objective.
• Shell Status: Acknowledge the company's status as a shell company with no active revenue-generating operations.